Bibliography
- ILIES MA, SCOZZAFAVA A, SUPURAN CT: Therapeutic applications of serine protease inhibitors. Expert Opin. Ther. Patents (2002) 12(8):1181–1214.
- ••A comprehensive and up-to-date overviewof the major important targets within the serine protease class.
- STEINKUHLER C, KOCH U, NARJES F et al.: Hepatitis C virus serine protease inhibitors: current progress and future challenges. Curr: Med. Chem. (2001) 8:919–932.
- ••A comprehensive review focused on HCVserine protease inhibitors.
- KWONG AD, KIM JL, RAO G et al: Hepatitis C virus NS3/4A protease. Antiviral Res. (1998) 40:1–18.
- ••An excellent review on NS3/4A HCVprotease as a pharmacological target.
- WALKER MA: Hepatitis C virus: an overview of current approaches and progress. Drug Discovery Today(1999) 4(11):518–529.
- ••A comprehensive overview on HCV,emphasising the different approaches undertaken by the pharmaceutical industry to deal with this viral disease.
- HOUGHTON M, WEINER A, HAN JH et al.: Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology (1991) 14:381–388.
- HOUGHTON M: Hepatitis C viruses. In: Virology Fields BN, Knipe DM, Howley PM (Eds), Raven Press, New York (1996):1035–1058.
- VAN DER POEL CL: Hepatitis C virus. Epidemiology, transmission and prevention. In: Current Studies in Hematology and Blood Transfusion. Reesink, HW (Ed.), Karger, Basel (1994):137–163.
- DAVIS GL: Combination treatment with interferon and ribavirin for chronic hepatitis C. Clin. Liver Dis. (1999) 3(4):811–826.
- MC HUTCHISON JG, GORDON Sc, SCHIFF ER et al: Interferon a-26 alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. New Engl. Med. (1998) 339:1485–1492.
- BARRETT AJ, RAWLINGS ND, WOESSSNER JF: Handbook of Proteolytic Enzymes (CD-ROM). Academic Press, London (1998).
- BABINE RE, BENDER SL: Molecular recognition of protein-ligand complexes: applications to drug design. Chem. Rev (1997) 97:1359–1472.
- LOVE RA, PARGE HE, WICKERSHAM JA et al: The crystal structure of hepatitis C virus N53 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell (1996) 87:331–342.
- YAO N, REICHERT P, TAREMI SS et al: Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase. Structure Fold. Des. (1999) 7(11):1353–1363.
- BARTENSCHLAGER R, KOCH JO: The hepatitis C virus NS-3 serine-type protease. In: Protease and Peptidase Inhibition - Recent Potential Targets for Drug Development. Smith HJ, Simons C (Eds), Taylor & Francis, London and New York (2002):333–351.
- INGALLINELLA P, ALTAMURA S, BIANCHI E et al.: Potent peptide inhibitors of human hepatitis C virus N53 protease are obtained by optimizing the cleavage products. Biochemistry (1998) 37(25):8906–8914.
- INGALLINELLA P, FATTORI D, ALTAMURA S et al: Prime site inhibitors of a serine protease: N53/4A of hepatitis C virus. Biochemistry (2002) 41:5483–5492.
- LLINAS-BRUNET M, BAILEY M, FAZAL G et al.: Peptide-based inhibitors of the hepatitis C virus serine protease. Biorg. Med. Chem. Lett. (1998) 8(13):1713–1718.
- LLINAS-BRUNET M, BAILEY M, DEZIEL R et al: Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease. Biorg. Med. Chem. Lett. (1998) 8(19):2719–2724.
- LOHMANN V, KORNER F, KOCH J et al: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science (1999) 285(5424):110–113.
- KOLYKHALOV AA, MIHALIK K, FEINSTONE SM et al.: Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. Virol (2000) 74:2046–2051.
- JONES LJ, YUE ST, CHEUNG CY et al.: RNA quantitation by fluorescent-based solution assay: RiboGreen reagent characterization. Anal. Biochem. (1998) 265(2):368–374.